Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3.
about
Hemoglobin and its scavenger protein haptoglobin associate with apoA-1-containing particles and influence the inflammatory properties and function of high density lipoproteinAssociation between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) studyHigh density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular riskAdvances in the Study of the Antiatherogenic Function and Novel Therapies for HDLHigh-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literatureCholesterol: the good, the bad, and the ugly - therapeutic targets for the treatment of dyslipidemiaHDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disordersTargeting the SR-B1 Receptor as a Gateway for Cancer Therapy and ImagingIdentification and profiling of targeted oxidized linoleic acid metabolites in rat plasma by quadrupole time-of-flight mass spectrometryA high throughput biochemical fluorometric method for measuring lipid peroxidation in HDLOxpholipin 11D: an anti-inflammatory peptide that binds cholesterol and oxidized phospholipidsABCG1 deficiency in mice promotes endothelial activation and monocyte-endothelial interactions.Oxidative risk for atherothrombotic cardiovascular disease.Dysfunctional HDL as a diagnostic and therapeutic targetOxidizability assay of unfractionated plasma of patients' with different plasma profile: a methodological study.Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis.Does metformin increase paraoxonase activity in patients with the metabolic syndrome? Additional data from the MEFISTO studyExtracellular hydrophobic regions in scavenger receptor BI play a key role in mediating HDL-cholesterol transport.Oxidized LDL: diversity, patterns of recognition, and pathophysiology.High-Density Lipoprotein Proteomics: Identifying New Drug Targets and Biomarkers by Understanding Functionality.Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes.Anti-oxidant properties of high-density lipoprotein and atherosclerosis5A, an apolipoprotein A-I mimetic peptide, attenuates the induction of house dust mite-induced asthmaCarotid intima media thickness and low high-density lipoprotein (HDL) in South Asian immigrants: could dysfunctional HDL be the missing link?Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatmentL-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in miceBiological properties of apolipoprotein a-I mimetic peptides.Anion exchange HPLC isolation of high-density lipoprotein (HDL) and on-line estimation of proinflammatory HDLZebrafish as a model for apolipoprotein biology: comprehensive expression analysis and a role for ApoA-IV in regulating food intake.Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasmaLow levels of serum paraoxonase activities are characteristic of metabolic syndrome and may influence the metabolic-syndrome-related risk of coronary artery disease.Accelerated vascular disease in systemic lupus erythematosus: role of macrophage.Association of paraoxonase 1 gene polymorphism and enzyme activity with carotid plaque in rheumatoid arthritis.A biochemical fluorometric method for assessing the oxidative properties of HDL.Type I diabetes mellitus decreases in vivo macrophage-to-feces reverse cholesterol transport despite increased biliary sterol secretion in mice.High-density lipoprotein (HDL) cholesterol: leveraging practice-based biobank cohorts to characterize clinical and genetic predictors of treatment outcome.Relationship between concentration difference of different density lipoproteins and shear stress in atherosclerosisBeyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches.Proteomic profiling following immunoaffinity capture of high-density lipoprotein: association of acute-phase proteins and complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis.Apolipoprotein A-I mimetic peptide reverses impaired arterial healing after injury by reducing oxidative stress.
P2860
Q24309793-CE2B651E-9670-41BD-B0EF-89C5A17665F1Q24615705-6E654C83-E907-43A6-9184-696D3E05C296Q26775420-147F65A6-80DD-4E0C-8C89-1FD1F62DFB5EQ26801507-0906DE5D-705B-4C8A-B071-A2C7A3F38C4CQ26996600-2DA81424-AB3F-4F94-9221-3AB083D4B56CQ27013494-8E1268BB-2CB8-4C1B-948E-850E5773C2A6Q27691344-C0EC890E-C557-4DBC-A23F-F2D275D405EEQ28070244-0DAB93FC-DE0A-4B8E-B8C0-35928E6D4078Q28276422-F238FC1A-1734-4F1F-A02E-9E1A0C64981AQ28544713-E4A47A92-0FA8-45CF-8CD2-70C482F67284Q28752575-CF715D2D-313D-44F5-8397-E6486316039EQ30432802-4AFD8D2A-D6C0-4C92-BA4F-08E6BE136669Q33554184-9C922711-953F-4842-BECA-252A0A10B300Q33604003-8A5916C1-2B57-4112-9B61-6D5AA90A28FDQ33653555-1695253E-A3B1-4C02-9D51-1D4DE71BE893Q33687843-01461A30-393D-46BA-B195-EAF279D1A98BQ33713488-7830C01F-C24D-4A51-87C5-04CAC20A0110Q33783351-818A23D9-381A-4650-8B23-906AE70C4D48Q33879138-6EA26281-FA6F-4D5C-AEAF-79F2E126EDDBQ33980120-CD55C8E0-7D0E-4591-A351-08833E99D7BBQ34355358-F5CF0C55-0B09-415D-A3DC-F197B1AF1CFFQ34440172-F2B20885-8436-4A6F-8AA7-3A119FA211F6Q34449116-2C9D4F55-97B9-4A4D-9073-71A1325A7A09Q34466725-517F80F0-6258-4F9A-AA7E-EB80C80C0CDFQ34563216-966334D7-4FE2-430B-A410-534D0A3C1429Q34566942-CDD93A6B-C0EF-4F54-B7B6-DCDAC5B67F16Q34927488-DC4EFEB1-9C6F-4167-843E-FD6B5D8DDD07Q35114897-D5ECDB45-BFE2-45C0-9AB8-39768F20049FQ35144039-D7E82778-3663-48F0-BB8E-D3210FCDA7B8Q35212906-9701ED27-9872-4BAF-A35E-1A266C20831FQ35231847-AA869BE8-1596-4CF4-B3DE-4A5A26AA47A6Q35539166-EEA8E9B1-E8C3-4B27-8EDF-85945AA08FE6Q35541874-DCEEAA94-C194-41DD-A6DB-B69C68E894D9Q35562004-1448278C-A264-465F-8B3B-428C280D3FEEQ35747737-AB1D5843-E049-48A2-B011-9DD60C6122E0Q35844499-936A740A-DD33-4C41-9B61-8DF90A485667Q35846328-276C91DF-9FF3-4669-AE7B-DC0BEFF2224CQ35860029-659728FE-A533-4FC6-8F01-87B2CD0DD652Q35899148-3395BC28-91DD-4D06-A85D-3313CE538738Q35928385-9851DFE8-6F60-44DE-9D69-D37118C0F342
P2860
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Normal high density lipoprotei ...... ty lipoprotein: steps 2 and 3.
@en
type
label
Normal high density lipoprotei ...... ty lipoprotein: steps 2 and 3.
@en
prefLabel
Normal high density lipoprotei ...... ty lipoprotein: steps 2 and 3.
@en
P2093
P1476
Normal high density lipoprotei ...... ty lipoprotein: steps 2 and 3.
@en
P2093
Anantharamaiah GM
Fogelman AM
Fonarow GC
Sevanian A
P304
P577
2000-09-01T00:00:00Z